Vina Churdboonchart
Corporate Officer/Principal at Mahidol University
Profile
Dr. Vina Churdboonchart is President at Trinity Medical Group, Inc. and a Member at Mahidol University.
Vina Churdboonchart active positions
| Companies | Position | Start |
|---|---|---|
| Mahidol University | Corporate Officer/Principal | 2010-02-24 |
Former positions of Vina Churdboonchart
| Companies | Position | End |
|---|---|---|
Trinity Medical Group, Inc.
 Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Founder | 2010-02-24 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Trinity Medical Group, Inc.
Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Commercial Services |
- Stock Market
- Insiders
- Vina Churdboonchart